892. Clinical Impact of Early Antifungal De-escalation (≤ 2 days) based on Rapid Species Identification in Patients with Azole-susceptible Candidemia

Lee, S., Mazur, S., Mazur, S., Kodiyanplakkal, R. P., Theodore, D., & Kubin, C. J. (2022). 892. Clinical Impact of Early Antifungal De-escalation (≤ 2 days) based on Rapid Species Identification in Patients with Azole-susceptible Candidemia. Open Forum Infectious Diseases, 9(Supplement_2). https://doi.org/10.1093/ofid/ofac492.737
Authors:
Sara Lee
Shawn Mazur
Shawn Mazur
Rosy Priya Kodiyanplakkal
Deborah Theodore
Christine J. Kubin
Affiliated Authors:
Sara Lee
Shawn Mazur
Shawn Mazur
Rosy Priya Kodiyanplakkal
Deborah Theodore
Christine J. Kubin
Columbia Affiliation:
Subjects:
Diagnosis and Management of Fungal Infections (OpenAlex Topic)
Management of Febrile Neutropenia in Cancer Patients (OpenAlex Topic)
Epidemiology and Management of Fungal Infections (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1093/ofid/ofac492.737
DOI:
10.1093/ofid/ofac492.737
Journal:
Open Forum Infectious Diseases
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: